Garfield, Alastair S., Davies, Jennifer S., Burke, Luke K., Furby, Hannah ORCID: https://orcid.org/0000-0002-7279-1812, Wilkinson, Lawrence ORCID: https://orcid.org/0000-0002-9337-6124, Heisler, Lora K. and Isles, Anthony Roger ORCID: https://orcid.org/0000-0002-7587-5712 2016. Increased alternate splicing of Htr2c in a mouse model for Prader-Willi syndrome leads disruption of 5HT2C receptor mediated appetite. Molecular Brain 9 , 95. 10.1186/s13041-016-0277-4 |
Preview |
PDF
- Published Version
Available under License Creative Commons Attribution. Download (463kB) | Preview |
Abstract
Alternate splicing of serotonin (5-hydroxytryptamine; 5-HT) 2C receptor (5-HT2CR) pre-RNA is negatively regulated by the small nucleolar RNA, Snord115, loss of which is observed in nearly all individuals with Prader-Willi Syndrome (PWS), a multigenic disorder characterised by hyperphagia and obesity. Given the role of the 5-HT2CR in the regulation of ingestive behaviour we investigated the pathophysiological implications of Snord115 deficiency on 5-HT2CR regulated appetite in a genotypically relevant PWS mouse model (PWS-IC). Specifically, we demonstrate that loss of Snord115 expression is associated with increased levels of hypothalamic truncated 5-HT2CR pre-mRNA. The 5-HT2CR promotes appetite suppression via engagement of the central melanocortin system. Pro-opiomelancortin (Pomc) mRNA levels within the arcuate nucleus of the hypothalamus (ARC) were reduced in PWS-IC mice. We then went on to assess the functional consequences of these molecular changes, demonstrating that PWS-IC mice are unresponsive to an anorectic doses of a 5-HT2CR agonist and that this is associated with attenuated activation of POMC neurons within the ARC. These data provide new insight into the significance of Htr2c pre-mRNA processing to the physiological regulation of appetite and potentially the pathological manifestation of hyperphagia in PWS. Furthermore, these findings have translational relevance for individuals with PWS who may seek to control appetite with another 5-HT2CR agonist, the new obesity treatment lorcaserin.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Medicine MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG) Neuroscience and Mental Health Research Institute (NMHRI) Psychology |
Subjects: | R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry |
Uncontrolled Keywords: | Snord115 – Prader-Willi syndrome – Serotonin 2C recptor – Alternate splicing – Feeding |
Publisher: | Biomed Central |
ISSN: | 1756-6606 |
Funders: | BBSRC |
Date of First Compliant Deposit: | 5 December 2016 |
Date of Acceptance: | 30 November 2016 |
Last Modified: | 02 May 2023 16:53 |
URI: | https://orca.cardiff.ac.uk/id/eprint/96630 |
Citation Data
Cited 34 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
Edit Item |